Long-term outcome of risankizumab in Crohn ’s disease: a real-world GETAID study

The aim of this study was to assess the long-term effectiveness and safety of risankizumab maintenance treatment in a large real-world cohort of patients with CD.

Source: Clinical Gastroenterology and Hepatology - May 8, 2024 Category: Gastroenterology Authors: Mathurin Fumery, Benedicte Caron, Xavier H ébuterne, Romain Altwegg, Xavier Roblin, Carmen Stefanescu, Antoine Meyer, Maria Nachury, David Laharie, Catherine Le Berre, Lucas Guillo, Amélie Biron, Ludovic Caillo, Anthony Buisson, Stephane Nancey, Mathieu Source Type: research